News in brief: CVD risk in cancer patients treated with hormonal therapy; New ctDNA test independent of tumour mutations

Hormone therapy and CVD risk consensus achieved The American Heart Association has issued a consensus statement on the cardiovascular risks associated with hormonal therapies used to treat breast and prostate cancer. Some of the findings include: Improvements in breast cancer outcomes with use of more than one hormone therapy come at the cost of higher ...

Already a member?

Login to keep reading.

© 2022 the limbic